Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

doi:10.1083/jcb.124.4.557

This Article

Full Text (PDF, 2293K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JCB

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Lopez-Casillas, F.

Articles by Massague, J.

Search for Related Content

PubMed

PubMed Citation

Articles by Lopez-Casillas, F.

Articles by Massague, J.

Pubmed/NCBI databases

Gene	GEO Profiles
HomoloGene	Protein
UniGene
Substance via MeSH
Genetics Home Reference

Social Bookmarking

What's this?

ARTICLES

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

F Lopez-Casillas, HM Payne, JL Andres and J Massague
Cell Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Betaglycan, also known as the TGF-beta type III receptor, is a membrane- anchored proteoglycan that presents TGF-beta to the type II signaling receptor, a transmembrane serine/threonine kinase. The betaglycan extracellular region, which can be shed by cells into the medium, contains a NH2-terminal domain related to endoglin and a COOH-terminal domain related to uromodulin, sperm receptors Zp2 and 3, and pancreatic secretory granule GP-2 protein. We identified residues Ser535 and Ser546 in the uromodulin-related region as the glycosaminoglycan (GAG) attachment sites. Their mutation to alanine prevents GAG attachment but does not interfere with betaglycan stability or ability to bind and present TGF-beta to receptor II. Using a panel of deletion mutants, we found that TGF-beta binds to the NH2-terminal endoglin-related region of betaglycan. The remainder of the extracellular domain and the cytoplasmic domain are not required for presentation of TGF-beta to receptor II; however, membrane anchorage is required. Soluble betaglycan can bind TGF-beta but does not enhance binding to membrane receptors. In fact, recombinant soluble betaglycan acts as potent inhibitor of TGF-beta binding to membrane receptors and blocks TGF-beta action, this effect being particularly pronounced with the TGF-beta 2 isoform. The results suggest that release of betaglycan into the medium converts this enhancer of TGF-beta action into a TGF-beta antagonist.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Bilandzic, M., Chu, S., Farnworth, P. G., Harrison, C., Nicholls, P., Wang, Y., Escalona, R. M., Fuller, P. J., Findlay, J. K., Stenvers, K. L. (2009). Loss of Betaglycan Contributes to the Malignant Properties of Human Granulosa Tumor Cells. Mol. Endocrinol. 23: 539-548 [Abstract] [Full Text]
Margulis, V., Maity, T., Zhang, X.-Y., Cooper, S. J., Copland, J. A., Wood, C. G. (2008). Type III Transforming Growth Factor-{beta} (TGF-{beta}) Receptor Mediates Apoptosis in Renal Cell Carcinoma Independent of the Canonical TGF-{beta} Signaling Pathway. Clin. Cancer Res. 14: 5722-5730 [Abstract] [Full Text]
Verona, E. V., Tang, Y., Millstead, T. K., Hinck, A. P., Agyin, J. K., Sun, L.-Z. (2008). Expression, purification and characterization of BGERII: a novel pan-TGF{beta} inhibitor. Protein Eng Des Sel 21: 463-473 [Abstract] [Full Text]
Kirkbride, K. C., Townsend, T. A., Bruinsma, M. W., Barnett, J. V., Blobe, G. C. (2008). Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-{beta} Type III Receptor. J. Biol. Chem. 283: 7628-7637 [Abstract] [Full Text]
Finger, E. C., Turley, R. S., Dong, M., How, T., Fields, T. A., Blobe, G. C. (2008). T{beta}RIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Carcinogenesis 29: 528-535 [Abstract] [Full Text]
Gordon, K. J., Dong, M., Chislock, E. M., Fields, T. A., Blobe, G. C. (2008). Loss of type III transforming growth factor {beta} receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis 29: 252-262 [Abstract] [Full Text]
Van Lint, P., Libert, C. (2007). Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol. 82: 1375-1381 [Abstract] [Full Text]
Nakajima, M., Kizawa, H., Saitoh, M., Kou, I., Miyazono, K., Ikegawa, S. (2007). Mechanisms for Asporin Function and Regulation in Articular Cartilage. J. Biol. Chem. 282: 32185-32192 [Abstract] [Full Text]
Sharifi, N., Lechleider, R. J, Farrar, W. L (2007). Transforming growth factor-{beta} receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate?. J Mol Endocrinol 39: 329-332 [Abstract] [Full Text]
Turley, R. S., Finger, E. C., Hempel, N., How, T., Fields, T. A., Blobe, G. C. (2007). The Type III Transforming Growth Factor-{beta} Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer. Cancer Res. 67: 1090-1098 [Abstract] [Full Text]
Juarez, P., Vilchis-Landeros, M. M., Ponce-Coria, J., Mendoza, V., Hernandez-Pando, R., Bobadilla, N. A., Lopez-Casillas, F. (2007). Soluble betaglycan reduces renal damage progression in db/db mice. Am. J. Physiol. Renal Physiol. 292: F321-F329 [Abstract] [Full Text]
Bangi, E., Wharton, K. (2006). Dual function of the Drosophila Alk1/Alk2 ortholog Saxophone shapes the Bmp activity gradient in the wing imaginal disc. Development 133: 3295-3303 [Abstract] [Full Text]
Lin, S J., Lerch, T. F, Cook, R. W, Jardetzky, T. S, Woodruff, T. K (2006). The structural basis of TGF-{beta}, bone morphogenetic protein, and activin ligand binding.. Reproduction 132: 179-190 [Abstract] [Full Text]
Finnson, K. W., Tam, B. Y. Y., Liu, K., Marcoux, A., Lepage, P., Roy, S., Bizet, A. A., Philip, A. (2006). Identification of CD109 as part of the TGF-{beta} receptor system in human keratinocytes. FASEB J. 20: 1525-1527 [Abstract] [Full Text]
Wiater, E., Harrison, C. A., Lewis, K. A., Gray, P. C., Vale, W. W. (2006). Identification of Distinct Inhibin and Transforming Growth Factor beta-binding Sites on Betaglycan: FUNCTIONAL SEPARATION OF BETAGLYCAN CO-RECEPTOR ACTIONS. J. Biol. Chem. 281: 17011-17022 [Abstract] [Full Text]
Janssens, K, Vanhoenacker, F, Bonduelle, M, Verbruggen, L, Van Maldergem, L, Ralston, S, Guanabens, N, Migone, N, Wientroub, S, Divizia, M T, Bergmann, C, Bennett, C, Simsek, S, Melancon, S, Cundy, T, Van Hul, W (2006). Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J. Med. Genet. 43: 1-11 [Abstract] [Full Text]
Janssens, K., ten Dijke, P., Janssens, S., Van Hul, W. (2005). Transforming Growth Factor-{beta}1 to the Bone. Endocr. Rev. 26: 743-774 [Abstract] [Full Text]
De Crescenzo, G., Pham, P. L., Durocher, Y., Chao, H., O'Connor-McCourt, M. D. (2004). Enhancement of the Antagonistic Potency of Transforming Growth Factor-{beta} Receptor Extracellular Domains by Coiled Coil-induced Homo- and Heterodimerization. J. Biol. Chem. 279: 26013-26018 [Abstract] [Full Text]
Velasco-Loyden, G., Arribas, J., Lopez-Casillas, F. (2004). The Shedding of Betaglycan Is Regulated by Pervanadate and Mediated by Membrane Type Matrix Metalloprotease-1. J. Biol. Chem. 279: 7721-7733 [Abstract] [Full Text]
Tam, B. Y. Y., Finnson, K. W., Philip, A. (2003). Glycosylphosphatidylinositol-anchored Proteins Regulate Transforming Growth Factor-{beta} Signaling in Human Keratinocytes. J. Biol. Chem. 278: 49610-49617 [Abstract] [Full Text]
Stenvers, K. L., Tursky, M. L., Harder, K. W., Kountouri, N., Amatayakul-Chantler, S., Grail, D., Small, C., Weinberg, R. A., Sizeland, A. M., Zhu, H.-J. (2003). Heart and Liver Defects and Reduced Transforming Growth Factor {beta}2 Sensitivity in Transforming Growth Factor {beta} Type III Receptor-Deficient Embryos. Mol. Cell. Biol. 23: 4371-4385 [Abstract] [Full Text]
Lopez-Casillas, F., Riquelme, C., Perez-Kato, Y., Ponce-Castaneda, M. V., Osses, N., Esparza-Lopez, J., Gonzalez-Nunez, G., Cabello-Verrugio, C., Mendoza, V., Troncoso, V., Brandan, E. (2003). Betaglycan Expression Is Transcriptionally Up-regulated during Skeletal Muscle Differentiation. CLONING OF MURINE BETAGLYCAN GENE PROMOTER AND ITS MODULATION BY MyoD, RETINOIC ACID, AND TRANSFORMING GROWTH FACTOR-beta. J. Biol. Chem. 278: 382-390 [Abstract] [Full Text]
Ethier, J.-F., Farnworth, P. G., Findlay, J. K., Ooi, G. T. (2002). Transforming Growth Factor-{beta} Modulates Inhibin A Bioactivity in the L{beta}T2 Gonadotrope Cell Line by Competing for Binding to Betaglycan. Mol. Endocrinol. 16: 2754-2763 [Abstract] [Full Text]
Bandyopadhyay, A., Lopez-Casillas, F., Malik, S. N., Montiel, J. L., Mendoza, V., Yang, J., Sun, L-Z. (2002). Antitumor Activity of a Recombinant Soluble Betaglycan in Human Breast Cancer Xenograft. Cancer Res. 62: 4690-4695 [Abstract] [Full Text]
Szweras, M., Liu, D., Partridge, E. A., Pawling, J., Sukhu, B., Clokie, C., Jahnen-Dechent, W., Tenenbaum, H. C., Swallow, C. J., Grynpas, M. D., Dennis, J. W. (2002). alpha 2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-beta /Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling. J. Biol. Chem. 277: 19991-19997 [Abstract] [Full Text]
LIU, M., SUGA, M., MACLEAN, A. A., ST. GEORGE, J. A., SOUZA, D. W., KESHAVJEE, S. (2002). Soluble Transforming Growth Factor-beta Type III Receptor Gene Transfection Inhibits Fibrous Airway Obliteration in a Rat Model of Bronchiolitis Obliterans. Am. J. Respir. Crit. Care Med. 165: 419-423 [Abstract] [Full Text]
Eickelberg, O., Centrella, M., Reiss, M., Kashgarian, M., Wells, R. G. (2002). Betaglycan Inhibits TGF-beta Signaling by Preventing Type I-Type II Receptor Complex Formation. GLYCOSAMINOGLYCAN MODIFICATIONS ALTER BETAGLYCAN FUNCTION. J. Biol. Chem. 277: 823-829 [Abstract] [Full Text]
Akman, H. O., Zhang, H., Siddiqui, M. A. Q., Solomon, W., Smith, E. L. P., Batuman, O. A. (2001). Response to hypoxia involves transforming growth factor-beta 2 and Smad proteins in human endothelial cells. Blood 98: 3324-3331 [Abstract] [Full Text]
Rowland-Goldsmith, M. A., Maruyama, H., Kusama, T., Ralli, S., Korc, M. (2001). Soluble Type II Transforming Growth Factor-{beta} (TGF-{beta}) Receptor Inhibits TGF-{beta} Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation. Clin. Cancer Res. 7: 2931-2940 [Abstract] [Full Text]
Bernard, D. J., Woodruff, T. K. (2001). Inhibin Binding Protein in Rats: Alternative Transcripts and Regulation in the Pituitary across the Estrous Cycle. Mol. Endocrinol. 15: 654-667 [Abstract] [Full Text]
Chong, H., Pangas, S. A., Bernard, D. J., Wang, E., Gitch, J., Chen, W., Draper, L. B., Cox, E. T., Woodruff, T. K. (2000). Structure and Expression of a Membrane Component of the Inhibin Receptor System. Endocrinology 141: 2600-2607 [Abstract] [Full Text]
Favoni, R. E., De Cupis, A. (2000). The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach. Pharmacol. Rev. 52: 179-206 [Abstract] [Full Text]
LI, C., HAMPSON, I. N., HAMPSON, L., KUMAR, P., BERNABEU, C., KUMAR, S. (2000). CD105 antagonizes the inhibitory signaling of transforming growth factor {beta}1 on human vascular endothelial cells. FASEB J. 14: 55-64 [Abstract] [Full Text]
PIEK, E., HELDIN, C.-H., TEN DIJKE, P. (1999). Specificity, diversity, and regulation in TGF-{beta} superfamily signaling. FASEB J. 13: 2105-2124 [Abstract] [Full Text]
Ji, C., Chen, Y., McCarthy, T. L., Centrella, M. (1999). Cloning the Promoter for Transforming Growth Factor-beta Type III Receptor. BASAL AND CONDITIONAL EXPRESSION IN FETAL RAT OSTEOBLASTS. J. Biol. Chem. 274: 30487-30494 [Abstract] [Full Text]
Binkert, C., Demetriou, M., Sukhu, B., Szweras, M., Tenenbaum, H. C., Dennis, J. W. (1999). Regulation of Osteogenesis by Fetuin. J. Biol. Chem. 274: 28514-28520 [Abstract] [Full Text]
Bandyopadhyay, A., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., Sun, L. (1999). A Soluble Transforming Growth Factor {beta} Type III Receptor Suppresses Tumorigenicity and Metastasis of Human Breast Cancer MDA-MB-231 Cells. Cancer Res. 59: 5041-5046 [Abstract] [Full Text]
Smith, J. D., Bryant, S. R., Couper, L. L., Vary, C. P. H., Gotwals, P. J., Koteliansky, V. E., Lindner, V. (1999). Soluble Transforming Growth Factor-� Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial Growth. Circ. Res. 84: 1212-1222 [Abstract] [Full Text]
Brown, C. B., Boyer, A. S., Runyan, R. B., Barnett, J. V. (1999). Requirement of Type III TGF- Receptor for Endocardial Cell Transformation in the Heart. Science 283: 2080-2082 [Abstract] [Full Text]
Barbara, N. P., Wrana, J. L., Letarte, M. (1999). Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-beta Superfamily. J. Biol. Chem. 274: 584-594 [Abstract] [Full Text]
Letamendia, A., Lastres, P., Botella, L. M., Raab, U., Langa, C., Velasco, B., Attisano, L., Bernabeu, C. (1998). Role of Endoglin in Cellular Responses to Transforming Growth Factor-beta . A COMPARATIVE STUDY WITH BETAGLYCAN. J. Biol. Chem. 273: 33011-33019 [Abstract] [Full Text]
Khalsa, O, Yoon, J., Torres-Schumann, S, Wharton, K. (1998). TGF-beta/BMP superfamily members, Gbb-60A and Dpp, cooperate to provide pattern information and establish cell identity in the Drosophila wing. Development 125: 2723-2734 [Abstract]
Dolan, M., Horchar, T., Rigatti, B., Hassell, J. R. (1997). Identification of Sites in Domain I of Perlecan That Regulate Heparan Sulfate Synthesis. J. Biol. Chem. 272: 4316-4322 [Abstract] [Full Text]
Haerry, T., Heslip, T., Marsh, J., O'Connor, M. (1997). Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila. Development 124: 3055-3064 [Abstract]
Ryden, M., Imamura, T., Jornvall, H., Belluardo, N., Neveu, I., Trupp, M., Okadome, T., ten Dijke, P., Ibanez, C. F. (1996). A Novel Type I Receptor Serine-Threonine Kinase Predominantly Expressed in the Adult Central Nervous System. J. Biol. Chem. 271: 30603-30609 [Abstract] [Full Text]
Retzler, C., Wiedemann, H., Kulbe, G., Rauch, U. (1996). Structural and Electron Microscopic Analysis of Neurocan and Recombinant Neurocan Fragments. J. Biol. Chem. 271: 17107-17113 [Abstract] [Full Text]
Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H. C., Dennis, J. W. (1996). Fetuin/alpha 2-HS Glycoprotein Is a Transforming Growth Factor-beta Type II Receptor Mimic and Cytokine Antagonist. J. Biol. Chem. 271: 12755-12761 [Abstract] [Full Text]
Zhang, L., David, G., Esko, J. D. (1995). Repetitive Ser-Gly Sequences Enhance Heparan Sulfate Assembly in Proteoglycans. J. Biol. Chem. 270: 27127-27135 [Abstract] [Full Text]
Rodriguez, C., Chen, F., Weinberg, R. A., Lodish, H. F. (1995). Cooperative Binding of Transforming Growth Factor (TGF)-[IMAGE]2 to the Types I and II TGF-[IMAGE] Receptors. J. Biol. Chem. 270: 15919-15922 [Abstract] [Full Text]
Zhang, L., Esko, J. D. (1995). Accumulation of a Pentasaccharide Terminating in [IMAGE]-N-Acetylglucosamine in an Animal Cell Mutant Defective in Heparan Sulfate Biosynthesis. J. Biol. Chem. 270: 12557-12562 [Abstract] [Full Text]
Yin, W., Smiley, E., Germiller, J., Mecham, R. P., Florer, J. B., Wenstrup, R. J., Bonadio, J. (1995). Isolation of a Novel Latent Transforming Growth Factor-[IMAGE] Binding Protein Gene (LTBP-3). J. Biol. Chem. 270: 10147-10160 [Abstract] [Full Text]
Brand, T., Schneider, M. D. (1995). Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription. J. Biol. Chem. 270: 8274-8284 [Abstract] [Full Text]
Taipale, J., Lohi, J., Saarinen, J., Kovanen, P. T., Keski-Oja, J. (1995). Human Mast Cell Chymase and Leukocyte Elastase Release Latent Transforming Growth Factor-beta1 from the Extracellular Matrix of Cultured Human Epithelial and Endothelial Cells. J. Biol. Chem. 270: 4689-4696 [Abstract] [Full Text]
Lin, H. Y., Moustakas, A., Knaus, P., Wells, R. G., Henis, Y. I., Lodish, H. F. (1995). The Soluble Exoplasmic Domain of the Type II Transforming Growth Factor (TGF)-beta Receptor. J. Biol. Chem. 270: 2747-2754 [Abstract] [Full Text]
Border, W. A., Noble, N. A. (1994). Transforming Growth Factor {beta} in Tissue Fibrosis. NEJM 331: 1286-1292 [Full Text]
Elenius, K, Jalkanen, M (1994). Function of the syndecans--a family of cell surface proteoglycans. J. Cell Sci. 107: 2975-2982
Esparza-Lopez, J., Montiel, J. L., Vilchis-Landeros, M. M., Okadome, T., Miyazono, K., Lopez-Casillas, F. (2001). Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-beta Superfamily. SPECIALIZED BINDING REGIONS FOR TRANSFORMING GROWTH FACTOR-beta AND INHIBIN A. J. Biol. Chem. 276: 14588-14596 [Abstract] [Full Text]
De Crescenzo, G., Grothe, S., Zwaagstra, J., Tsang, M., O'Connor-McCourt, M. D. (2001). Real-time Monitoring of the Interactions of Transforming Growth Factor-beta (TGF-beta ) Isoforms with Latency-associated Protein and the Ectodomains of the TGF-beta Type II and III Receptors Reveals Different Kinetic Models and Stoichiometries of Binding. J. Biol. Chem. 276: 29632-29643 [Abstract] [Full Text]
Blobe, G. C., Schiemann, W. P., Pepin, M.-C., Beauchemin, M., Moustakas, A., Lodish, H. F., O'Connor-McCourt, M. D. (2001). Functional Roles for the Cytoplasmic Domain of the Type III Transforming Growth Factor beta Receptor in Regulating Transforming Growth Factor beta Signaling. J. Biol. Chem. 276: 24627-24637 [Abstract] [Full Text]